Market Overview

5 Biggest Price Target Changes For Thursday

Share:
Related RARE
Ultragenyx Seeks An FDA Win For Biologic Therapy Candidate
The Week Ahead For November 13: Conferences, Earnings and IPO Events To Watch
Ultragenyx's MEPSEVII: A Look At The MPS Drug's Commercial Potential (Seeking Alpha)
Related FDX
Bill Gates: Tech Titan To Famed Investor
Analysis: US Postal Service, Built To Deliver Letters, Struggles To Compete In Package Delivery
Tracking Mason Hawkins' Southeastern Asset Management Portfolio - Q3 2017 Update (Seeking Alpha)
  • Wedbush lowered Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) price target from $88 to $80. Ultragenyx Pharmaceutical shares closed at $78.36 on Wednesday.
  • Baird raised FedEx Corporation (NYSE: FDX) price target from $209 to $222. FedEx shares closed at $195.92 on Wednesday.
  • Barclays increased the price target for Cintas Corporation (NASDAQ: CTAS) from $130 to $145. Cintas shares closed at $124.37 on Wednesday.
  • Citi raised the price target for Nike Inc (NYSE: NKE) from $60 to $66. Nike shares closed at $53.92 on Wednesday.
  • UBS increased PVH Corp (NYSE: PVH) price target from $112 to $116. PVH shares closed at $90.85 on Wednesday.

Latest Ratings for RARE

DateFirmActionFromTo
Nov 2017Canaccord GenuityMaintainsBuy
Nov 2017BairdMaintainsOutperform
Oct 2017Morgan StanleyMaintainsEqual-Weight

View More Analyst Ratings for RARE
View the Latest Analyst Ratings

Posted-In: Price Target ChangesPrice Target Analyst Ratings

 

Related Articles (CTAS + FDX)

View Comments and Join the Discussion!

Partner Center